• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vinorelbine/5-FU combination in metastatic breast cancer chemotherapy. A retrospective study of 63 cases.

作者信息

Cany L, Toulouse C, Ravaud A, Durand M, Mauriac L

出版信息

Eur J Cancer. 1996 Feb;32A(2):370-1. doi: 10.1016/0959-8049(95)00590-0.

DOI:10.1016/0959-8049(95)00590-0
PMID:8664059
Abstract
摘要

相似文献

1
Vinorelbine/5-FU combination in metastatic breast cancer chemotherapy. A retrospective study of 63 cases.长春瑞滨/5-氟尿嘧啶联合方案用于转移性乳腺癌化疗：63例回顾性研究。
Eur J Cancer. 1996 Feb;32A(2):370-1. doi: 10.1016/0959-8049(95)00590-0.
2
Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: significance of the time between initiation of adjuvant therapy and of therapy for metastatic breast cancer.
Ann Oncol. 2004 Jan;15(1):175; author reply 175. doi: 10.1093/annonc/mdh023.
3
Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer.长春瑞滨与持续输注5-氟尿嘧啶用于蒽环类和紫杉烷类预处理的转移性乳腺癌
Clin Oncol (R Coll Radiol). 2008 Mar;20(2):152-6. doi: 10.1016/j.clon.2007.10.013.
4
Individualized chemotherapy based on organ selectivity: a retrospective study of vinorelbine and capecitabine for patients with metastatic breast cancer.基于器官选择性的个体化化疗：长春瑞滨与卡培他滨治疗转移性乳腺癌患者的回顾性研究
Curr Med Res Opin. 2014 Jun;30(6):1017-24. doi: 10.1185/03007995.2014.895310. Epub 2014 Mar 10.
5
Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.长春瑞滨、5-氟尿嘧啶、左亚叶酸钙联合人粒细胞集落刺激因子有效治疗晚期乳腺癌
Br J Cancer. 1998 Sep;78(5):673-8. doi: 10.1038/bjc.1998.558.
6
Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).长春瑞滨与5-氟尿嘧啶大剂量和/或持续静脉输注联合亚叶酸钙作为转移性乳腺癌的二线化疗：意大利南部肿瘤学组（GOIM）临床实践结果分析
Anticancer Res. 2006 Jul-Aug;26(4B):3143-50.
7
Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?使用长春瑞滨、顺铂、5-氟尿嘧啶持续输注（ViFuP方案）化疗的乳腺癌患者静脉血栓栓塞的发生率：是否需要进行预防？
Ann Oncol. 2000 Jan;11(1):117-8. doi: 10.1023/a:1008364801718.
8
Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines.
J Clin Oncol. 2000 Oct 1;18(19):3370-7. doi: 10.1200/JCO.2000.18.19.3370.
9
Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review.长春瑞滨（诺维本）与米托蒽醌联合化疗治疗转移性乳腺癌的综述
Semin Oncol. 1995 Apr;22(2 Suppl 5):61-5.
10
Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.长春瑞滨、环磷酰胺和5-氟尿嘧啶联合治疗晚期乳腺癌的II期试验
In Vivo. 1998 Sep-Oct;12(5):559-62.

引用本文的文献

1
Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane.卡培他滨和长春瑞滨用于既往接受过蒽环类药物和紫杉烷治疗的转移性乳腺癌患者。
J Korean Med Sci. 2004 Aug;19(4):547-53. doi: 10.3346/jkms.2004.19.4.547.
2
Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure.多西他赛与5-氟尿嘧啶加长春瑞滨治疗蒽环类药物治疗失败后的转移性乳腺癌对比研究
Br J Cancer. 2002 Nov 18;87(11):1210-5. doi: 10.1038/sj.bjc.6600645.
3
Profound variation in dihydropyrimidine dehydrogenase activity in human blood cells: major implications for the detection of partly deficient patients.
人类血细胞中二氢嘧啶脱氢酶活性的显著差异：对部分缺陷患者检测的主要影响。
Br J Cancer. 1999 Feb;79(3-4):620-6. doi: 10.1038/sj.bjc.6690097.
4
Breast cancer therapies in development. A review of their pharmacology and clinical potential.正在研发的乳腺癌治疗方法。对其药理学及临床潜力的综述。
Drugs. 1997 Sep;54(3):385-413. doi: 10.2165/00003495-199754030-00003.